Picture of ST Pharm Co logo

237690 ST Pharm Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Annual cashflow statement for ST Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-18,529-13,1553,37717,51617,523
Depreciation
Amortisation
Non-Cash Items-3,384-1,05510,10015,60427,646
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital-19,789-20,793-20,622-43,689-66,898
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-30,517-20,9357,2707,0311,298
Capital Expenditures-6,314-17,444-51,918-60,663-43,443
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-3,452-51,63043,88554,939-38,945
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-9,766-69,074-8,034-5,724-82,388
Financing Cash Flow Items32.2-1,486-245462122
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities5,323115,927-11610,80881,401
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-34,88625,80257810,998-104